SIMILAR PATTERNS OF AMINO ACIDS FOR 4CTJ_A_SAMA1263_0
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1e08 | [FE]-HYDROGENASE(LARGE SUBUNIT) (Desulfovibriodesulfuricans) |
PF02906(Fe_hyd_lg_C)PF13187(Fer4_9) | 6 | GLY A 297GLY A 70GLY A 386GLY A 381VAL A 28ILE A 235 | PDT A 4 (-3.3A)SF4 A 2 (-3.8A)SF4 A 3 ( 4.3A)SF4 A 3 ( 3.9A)SF4 A 2 (-4.7A)None | 1.11A | 4ctjA-1e08A:undetectable | 4ctjA-1e08A:20.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1eiz | FTSJ (Escherichiacoli) |
PF01728(FtsJ) | 5 | GLY A 59GLY A 64TRP A 65ASP A 99ASP A 124 | SAM A 301 (-3.6A)SAM A 301 (-3.1A)SAM A 301 (-3.6A)SAM A 301 (-3.5A)SAM A 301 (-3.6A) | 0.39A | 4ctjA-1eizA:14.7 | 4ctjA-1eizA:22.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1elt | ELASTASE (Salmo salar) |
PF00089(Trypsin) | 6 | GLY A 142GLY A 44GLY A 197GLY A 193VAL A 52ILE A 31 | None | 1.28A | 4ctjA-1eltA:undetectable | 4ctjA-1eltA:20.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1kpl | PUTATIVE CLC FAMILY,CHLORINE TRANSPORTPROTEIN (Salmonellaenterica) |
PF00654(Voltage_CLC) | 5 | GLY A 196GLY A 408GLU A 203VAL A 222ILE A 197 | None | 0.84A | 4ctjA-1kplA:undetectable | 4ctjA-1kplA:22.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1l2q | MONOMETHYLAMINEMETHYLTRANSFERASE (Methanosarcinabarkeri) |
PF05369(MtmB) | 5 | GLY A 387GLY A 129GLY A 366THR A 131ILE A 156 | NoneNoneNoneXPL A 202 ( 4.5A)None | 0.78A | 4ctjA-1l2qA:undetectable | 4ctjA-1l2qA:21.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1muu | GDP-MANNOSE6-DEHYDROGENASE (Pseudomonasaeruginosa) |
PF00984(UDPG_MGDP_dh)PF03720(UDPG_MGDP_dh_C)PF03721(UDPG_MGDP_dh_N) | 5 | GLY A 147GLY A 153GLY A 151GLU A 178VAL A 125 | None | 0.84A | 4ctjA-1muuA:2.9 | 4ctjA-1muuA:21.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1op2 | VENOM SERINEPROTEINASE (Deinagkistrodonacutus) |
PF00089(Trypsin) | 6 | GLY A 142GLY A 44GLY A 196GLY A 193THR A 54VAL A 52 | None | 1.28A | 4ctjA-1op2A:undetectable | 4ctjA-1op2A:18.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1r6a | GENOME POLYPROTEIN (Dengue virus) |
PF01728(FtsJ) | 12 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105GLU A 111ASP A 131VAL A 132ASP A 146ILE A 147 | SAH A 887 (-3.0A)SAH A 887 (-3.6A)SAH A 887 (-3.6A)SAH A 887 (-3.3A)SAH A 887 (-3.5A)SAH A 887 (-4.5A)SO4 A 902 (-2.7A)NoneSAH A 887 ( 3.3A)SAH A 887 (-3.5A)SAH A 887 (-3.9A)SAH A 887 ( 4.2A) | 0.58A | 4ctjA-1r6aA:41.9 | 4ctjA-1r6aA:75.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1vcl | HEMOLYTIC LECTINCEL-III (Cucumariaechinata) |
PF00652(Ricin_B_lectin) | 6 | GLY A 215GLY A 220GLY A 217VAL A 169ASP A 209ILE A 221 | NoneNoneNone CA A1003 (-4.7A) CA A1004 (-2.6A)None | 1.35A | 4ctjA-1vclA:undetectable | 4ctjA-1vclA:20.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1vcw | PROTEASE DEGS (Escherichiacoli) |
PF13180(PDZ_2)PF13365(Trypsin_2) | 5 | GLY A 214GLY A 82GLY A 202VAL A 106ILE A 91 | None | 0.75A | 4ctjA-1vcwA:undetectable | 4ctjA-1vcwA:20.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ap1 | PUTATIVE REGULATORPROTEIN (Salmonellaenterica) |
PF00480(ROK) | 6 | GLY A 291GLY A 4GLY A 295VAL A 43ASP A 6ILE A 12 | None | 1.18A | 4ctjA-2ap1A:undetectable | 4ctjA-2ap1A:21.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2b25 | HYPOTHETICAL PROTEIN (Homo sapiens) |
PF08704(GCD14) | 5 | GLY A 111GLY A 113GLY A 116ASP A 173ASP A 192 | SAM A 601 (-2.9A)SAM A 601 (-3.2A)SAM A 601 (-3.5A)SAM A 601 (-3.4A)SAM A 601 (-3.5A) | 0.64A | 4ctjA-2b25A:8.2 | 4ctjA-2b25A:24.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2cfb | GLUTAMATE-1-SEMIALDEHYDE 2,1-AMINOMUTASE (Synechococcuselongatus) |
PF00202(Aminotran_3) | 6 | GLY A 260GLY A 294GLY A 255GLY A 250THR A 297ILE A 295 | None | 1.40A | 4ctjA-2cfbA:undetectable | 4ctjA-2cfbA:23.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2dup | VESICULARINTEGRAL-MEMBRANEPROTEIN VIP36 (Canis lupus) |
PF03388(Lectin_leg-like) | 6 | GLY A 132GLY A 258GLU A 98ASP A 267VAL A 120ILE A 133 | None | 1.46A | 4ctjA-2dupA:undetectable | 4ctjA-2dupA:21.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2et6 | (3R)-HYDROXYACYL-COADEHYDROGENASE (Candidatropicalis) |
PF00106(adh_short) | 5 | GLY A 333GLY A 404GLY A 329GLY A 335ILE A 405 | None | 0.86A | 4ctjA-2et6A:2.3 | 4ctjA-2et6A:18.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2nyu | PUTATIVE RIBOSOMALRNAMETHYLTRANSFERASE 2 (Homo sapiens) |
PF01728(FtsJ) | 5 | GLY A 30TRP A 36ASP A 79VAL A 80ASP A 104 | SAM A 201 (-3.5A)SAM A 201 (-3.9A)SAM A 201 (-3.3A)SAM A 201 (-3.9A)SAM A 201 (-3.7A) | 0.41A | 4ctjA-2nyuA:14.0 | 4ctjA-2nyuA:21.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2oxt | NUCLEOSIDE-2'-O-METHYLTRANSFERASE (Meaban virus) |
PF01728(FtsJ) | 8 | GLY A 59GLY A 82GLY A 84GLY A 87TRP A 88THR A 105ASP A 132ASP A 147 | SAM A 300 (-3.1A)SAM A 300 (-3.3A)SAM A 300 (-3.5A)SAM A 300 (-3.2A)SAM A 300 (-3.8A)SAM A 300 (-4.6A)SAM A 300 (-3.9A)SAM A 300 (-3.9A) | 0.38A | 4ctjA-2oxtA:39.6 | 4ctjA-2oxtA:51.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2oxt | NUCLEOSIDE-2'-O-METHYLTRANSFERASE (Meaban virus) |
PF01728(FtsJ) | 8 | GLY A 59GLY A 82GLY A 84GLY A 87TRP A 88THR A 105GLU A 112ASP A 132 | SAM A 300 (-3.1A)SAM A 300 (-3.3A)SAM A 300 (-3.5A)SAM A 300 (-3.2A)SAM A 300 (-3.8A)SAM A 300 (-4.6A)NoneSAM A 300 (-3.9A) | 0.62A | 4ctjA-2oxtA:39.6 | 4ctjA-2oxtA:51.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2oxt | NUCLEOSIDE-2'-O-METHYLTRANSFERASE (Meaban virus) |
PF01728(FtsJ) | 6 | GLY A 82GLY A 59GLY A 87GLY A 84THR A 60ASP A 147 | SAM A 300 (-3.3A)SAM A 300 (-3.1A)SAM A 300 (-3.2A)SAM A 300 (-3.5A)NoneSAM A 300 (-3.9A) | 1.34A | 4ctjA-2oxtA:39.6 | 4ctjA-2oxtA:51.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2oy0 | METHYLTRANSFERASE (West Nile virus) |
PF01728(FtsJ) | 11 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105ASP A 131VAL A 132ASP A 146ILE A 147 | SAH A 301 (-3.4A)SAH A 301 (-3.0A)SAH A 301 (-3.2A)SAH A 301 (-3.0A)SAH A 301 (-3.7A)SAH A 301 (-4.4A)NoneSAH A 301 (-3.2A)SAH A 301 (-3.8A)SAH A 301 (-4.2A)SAH A 301 ( 4.3A) | 0.49A | 4ctjA-2oy0A:40.5 | 4ctjA-2oy0A:61.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2oy0 | METHYLTRANSFERASE (West Nile virus) |
PF01728(FtsJ) | 6 | GLY A 58GLY A 83GLY A 86THR A 104LYS A 105GLU A 111 | SAH A 301 (-3.4A)SAH A 301 (-3.2A)SAH A 301 (-3.0A)SAH A 301 (-4.4A)NoneSAH A 301 (-3.5A) | 0.99A | 4ctjA-2oy0A:40.5 | 4ctjA-2oy0A:61.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2oy0 | METHYLTRANSFERASE (West Nile virus) |
PF01728(FtsJ) | 6 | GLY A 86TRP A 87LYS A 105VAL A 132ASP A 146ILE A 147 | SAH A 301 (-3.0A)SAH A 301 (-3.7A)NoneSAH A 301 (-3.8A)SAH A 301 (-4.2A)SAH A 301 ( 4.3A) | 1.50A | 4ctjA-2oy0A:40.5 | 4ctjA-2oy0A:61.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2px5 | GENOME POLYPROTEIN[CONTAINS: CAPSIDPROTEIN C (COREPROTEIN) ENVELOPE PROTEIN M(MATRIX PROTEIN) MAJOR ENVELOPEPROTEIN E NON-STRUCTURALPROTEIN 1 (NS1) NON-STRUCTURALPROTEIN 2A (NS2A) FLAVIVIRIN PROTEASENS2B REGULATORYSUBUNIT FLAVIVIRIN PROTEASENS3 CATALYTICSUBUNIT NON-STRUCTURALPROTEIN 4A (NS4A) NON-STRUCTURALPROTEIN 4B (NS4B) RNA-DIRECTED RNAPOLYMERASE (EC2.7.7.48) (NS5)] (Murray Valleyencephalitisvirus) |
PF01728(FtsJ) | 10 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104ASP A 131VAL A 132ASP A 146ILE A 147 | SAH A 500 (-3.3A)SAH A 500 (-3.4A)SAH A 500 ( 3.7A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)SAH A 500 (-3.5A)SAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A) | 0.29A | 4ctjA-2px5A:41.3 | 4ctjA-2px5A:60.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2px5 | GENOME POLYPROTEIN[CONTAINS: CAPSIDPROTEIN C (COREPROTEIN) ENVELOPE PROTEIN M(MATRIX PROTEIN) MAJOR ENVELOPEPROTEIN E NON-STRUCTURALPROTEIN 1 (NS1) NON-STRUCTURALPROTEIN 2A (NS2A) FLAVIVIRIN PROTEASENS2B REGULATORYSUBUNIT FLAVIVIRIN PROTEASENS3 CATALYTICSUBUNIT NON-STRUCTURALPROTEIN 4A (NS4A) NON-STRUCTURALPROTEIN 4B (NS4B) RNA-DIRECTED RNAPOLYMERASE (EC2.7.7.48) (NS5)] (Murray Valleyencephalitisvirus) |
PF01728(FtsJ) | 10 | GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105ASP A 131VAL A 132ASP A 146ILE A 147 | SAH A 500 (-3.4A)SAH A 500 ( 3.7A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)NoneSAH A 500 (-3.5A)SAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A) | 0.65A | 4ctjA-2px5A:41.3 | 4ctjA-2px5A:60.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2qy6 | UPF0209 PROTEIN YFCK (Escherichiacoli) |
PF05430(Methyltransf_30) | 5 | GLY A 86GLY A 88LYS A 122ASP A 176ASP A 198 | None | 0.79A | 4ctjA-2qy6A:3.9 | 4ctjA-2qy6A:21.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2r3u | PROTEASE DEGS (Escherichiacoli) |
PF13365(Trypsin_2) | 5 | GLY A 214GLY A 82GLY A 202VAL A 106ILE A 91 | None | 0.73A | 4ctjA-2r3uA:undetectable | 4ctjA-2r3uA:22.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2r9h | H(+)/CL(-) EXCHANGETRANSPORTER CLCA (Escherichiacoli) |
PF00654(Voltage_CLC) | 5 | GLY A 196GLY A 408GLU A 203VAL A 222ILE A 197 | None | 0.86A | 4ctjA-2r9hA:undetectable | 4ctjA-2r9hA:21.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2wa2 | NON-STRUCTURALPROTEIN 5 (Modoc virus) |
PF01728(FtsJ) | 10 | GLY A 59GLY A 82GLY A 84TRP A 88THR A 105GLU A 112ASP A 132VAL A 133ASP A 147ILE A 148 | SAM A1248 ( 3.7A)SAM A1248 (-3.3A)SAM A1248 (-3.4A)SAM A1248 (-3.7A)SAM A1248 (-4.5A)NoneSAM A1248 (-3.6A)SAM A1248 (-3.4A)SAM A1248 (-3.7A)SAM A1248 ( 4.0A) | 0.46A | 4ctjA-2wa2A:33.4 | 4ctjA-2wa2A:50.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xn8 | PUTATIVE CYTOCHROMEP450 125 (Mycobacteriumtuberculosis) |
PF00067(p450) | 5 | GLY A 56GLY A 60GLY A 62GLY A 69ASP A 58 | None | 0.74A | 4ctjA-2xn8A:undetectable | 4ctjA-2xn8A:22.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2z8z | LIPASE (Pseudomonas sp.MIS38) |
PF00353(HemolysinCabind) | 5 | GLY A 505GLY A 520GLY A 523ASP A 516ASP A 507 | None CA A 626 ( 4.6A) CA A 624 ( 3.3A) CA A 623 ( 2.3A)None | 0.85A | 4ctjA-2z8zA:undetectable | 4ctjA-2z8zA:19.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3dou | RIBOSOMAL RNA LARGESUBUNITMETHYLTRANSFERASE J (Thermoplasmavolcanium) |
PF01728(FtsJ) | 5 | GLY A 46GLY A 51TRP A 52ASP A 83ASP A 111 | SAM A 1 (-3.5A)SAM A 1 (-3.2A)SAM A 1 (-4.0A)SAM A 1 (-3.6A)SAM A 1 (-3.7A) | 0.46A | 4ctjA-3douA:13.7 | 4ctjA-3douA:19.13 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3elu | METHYLTRANSFERASE (Wesselsbronvirus) |
PF00972(Flavi_NS5)PF01728(FtsJ) | 10 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104GLU A 111VAL A 132ASP A 146ILE A 147 | SAM A4633 ( 3.7A)SAM A4633 (-3.2A)SAM A4633 (-3.4A)SAM A4633 (-3.4A)SAM A4633 (-3.5A)SAM A4633 (-4.5A)NoneSAM A4633 (-3.4A)SAM A4633 (-3.7A)SAM A4633 ( 4.2A) | 0.47A | 4ctjA-3eluA:39.3 | 4ctjA-3eluA:51.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3evc | RNA-DIRECTED RNAPOLYMERASE NS5 (Yellow fevervirus) |
PF01728(FtsJ) | 9 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104ASP A 131ASP A 146ILE A 147 | SAH A 901 (-3.2A)SAH A 901 (-3.4A)SAH A 901 (-3.3A)SAH A 901 (-3.1A)SAH A 901 (-3.6A)SAH A 901 (-4.5A)SAH A 901 (-3.7A)SAH A 901 (-3.8A)SAH A 901 ( 4.2A) | 0.28A | 4ctjA-3evcA:40.8 | 4ctjA-3evcA:51.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3evc | RNA-DIRECTED RNAPOLYMERASE NS5 (Yellow fevervirus) |
PF01728(FtsJ) | 6 | GLY A 81GLY A 58GLY A 86GLY A 83THR A 59ASP A 146 | SAH A 901 (-3.4A)SAH A 901 (-3.2A)SAH A 901 (-3.1A)SAH A 901 (-3.3A)NoneSAH A 901 (-3.8A) | 1.31A | 4ctjA-3evcA:40.8 | 4ctjA-3evcA:51.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3fq8 | GLUTAMATE-1-SEMIALDEHYDE 2,1-AMINOMUTASE (Synechococcuselongatus) |
PF00202(Aminotran_3) | 6 | GLY A1282GLY A1316GLY A1277GLY A1272THR A1319ILE A1317 | None | 1.43A | 4ctjA-3fq8A:undetectable | 4ctjA-3fq8A:21.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3g01 | GRANZYME C (Mus musculus) |
PF00089(Trypsin) | 5 | GLY A 149GLY A 52GLY A 206GLY A 202VAL A 60 | None | 0.85A | 4ctjA-3g01A:undetectable | 4ctjA-3g01A:21.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3g48 | CHAPERONE CSAA (Bacillusanthracis) |
PF01588(tRNA_bind) | 5 | GLY A 15GLY A 105GLU A 39ASP A 36ILE A 35 | None | 0.85A | 4ctjA-3g48A:undetectable | 4ctjA-3g48A:16.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3gcz | POLYPROTEIN (Yokose virus) |
PF01728(FtsJ) | 11 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104GLU A 111ASP A 131VAL A 132ASP A 146ILE A 147 | SAM A4633 (-3.5A)SAM A4633 (-3.4A)SAM A4633 (-3.4A)SAM A4633 (-3.2A)SAM A4633 (-3.6A)SAM A4633 (-4.5A)NoneSAM A4633 (-3.7A)SAM A4633 (-3.6A)SAM A4633 (-3.7A)SAM A4633 ( 4.2A) | 0.42A | 4ctjA-3gczA:41.2 | 4ctjA-3gczA:55.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3h7t | GROUP 3 ALLERGENSMIPP-S YVT004A06 (Sarcoptesscabiei) |
PF00089(Trypsin) | 6 | GLY A 126GLY A 28GLY A 187GLY A 184THR A 38VAL A 36 | None | 1.28A | 4ctjA-3h7tA:undetectable | 4ctjA-3h7tA:20.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3lgi | PROTEASE DEGS (Escherichiacoli) |
PF13365(Trypsin_2) | 5 | GLY A 214GLY A 82GLY A 202VAL A 106ILE A 91 | None | 0.70A | 4ctjA-3lgiA:undetectable | 4ctjA-3lgiA:22.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3lkz | NON-STRUCTURALPROTEIN 5 (West Nile virus) |
PF01728(FtsJ) | 11 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105ASP A 131VAL A 132ASP A 146ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)NoneSFG A 301 (-3.1A)SFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.45A | 4ctjA-3lkzA:41.3 | 4ctjA-3lkzA:54.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3lkz | NON-STRUCTURALPROTEIN 5 (West Nile virus) |
PF01728(FtsJ) | 7 | GLY A 58GLY A 83GLY A 86THR A 104LYS A 105GLU A 111VAL A 132 | SFG A 301 (-2.9A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 ( 4.7A)NoneSFG A 301 (-3.7A)SFG A 301 (-4.1A) | 0.89A | 4ctjA-3lkzA:41.3 | 4ctjA-3lkzA:54.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3lkz | NON-STRUCTURALPROTEIN 5 (West Nile virus) |
PF01728(FtsJ) | 6 | GLY A 81GLY A 58GLY A 86GLY A 83THR A 59ASP A 146 | SFG A 301 (-3.5A)SFG A 301 (-2.9A)SFG A 301 (-3.4A)SFG A 301 (-3.3A)NoneSFG A 301 (-3.8A) | 1.37A | 4ctjA-3lkzA:41.3 | 4ctjA-3lkzA:54.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3nf2 | PUTATIVE POLYPRENYLSYNTHETASE (Streptomycescoelicolor) |
PF00348(polyprenyl_synt) | 6 | GLY A 113GLY A 233GLY A 110THR A 103GLU A 174ASP A 357 | None | 1.43A | 4ctjA-3nf2A:undetectable | 4ctjA-3nf2A:20.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3nlc | UNCHARACTERIZEDPROTEIN VP0956 (Vibrioparahaemolyticus) |
no annotation | 6 | GLY A 104GLY A 162GLY A 159THR A 163GLU A 158ILE A 514 | FAD A 601 (-3.1A)FAD A 601 (-3.1A)NoneNoneNoneFAD A 601 (-3.9A) | 1.24A | 4ctjA-3nlcA:undetectable | 4ctjA-3nlcA:19.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3opy | 6-PHOSPHOFRUCTO-1-KINASE BETA-SUBUNIT (Komagataellapastoris) |
PF00365(PFK) | 5 | GLY B 383GLY B 433GLY B 380GLU B 432ILE B 442 | None | 0.83A | 4ctjA-3opyB:undetectable | 4ctjA-3opyB:14.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ps9 | TRNA5-METHYLAMINOMETHYL-2-THIOURIDINEBIOSYNTHESISBIFUNCTIONAL PROTEINMNMC (Escherichiacoli) |
PF01266(DAO)PF05430(Methyltransf_30) | 5 | GLY A 66GLY A 68LYS A 102ASP A 156ASP A 178 | SAM A 670 (-3.5A)SAM A 670 (-3.2A)SAM A 670 (-4.9A)SAM A 670 (-3.5A)SAM A 670 (-3.4A) | 0.85A | 4ctjA-3ps9A:5.5 | 4ctjA-3ps9A:18.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3pv2 | DEGQ (Legionellafallonii) |
PF13180(PDZ_2)PF13365(Trypsin_2) | 5 | GLY A 206GLY A 69GLY A 194VAL A 94ILE A 79 | None | 0.79A | 4ctjA-3pv2A:undetectable | 4ctjA-3pv2A:20.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3pv4 | DEGQ (Legionellafallonii) |
PF13180(PDZ_2)PF13365(Trypsin_2) | 5 | GLY A 206GLY A 69GLY A 194VAL A 94ILE A 79 | None | 0.80A | 4ctjA-3pv4A:undetectable | 4ctjA-3pv4A:20.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3pvc | TRNA5-METHYLAMINOMETHYL-2-THIOURIDINEBIOSYNTHESISBIFUNCTIONAL PROTEINMNMC (Yersinia pestis) |
PF01266(DAO)PF05430(Methyltransf_30) | 5 | GLY A 66GLY A 70ASP A 156VAL A 157ASP A 178 | None | 0.86A | 4ctjA-3pvcA:4.8 | 4ctjA-3pvcA:15.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3r1i | SHORT-CHAIN TYPEDEHYDROGENASE/REDUCTASE (Mycobacteriummarinum) |
PF13561(adh_short_C2) | 6 | GLY A 22GLY A 97GLY A 18GLY A 24ASP A 117ILE A 98 | None | 1.33A | 4ctjA-3r1iA:5.7 | 4ctjA-3r1iA:20.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3s69 | THROMBIN-LIKE ENZYMEDEFIBRASE (Gloydiussaxatilis) |
PF00089(Trypsin) | 6 | GLY A 139GLY A 43GLY A 196GLY A 193THR A 53VAL A 51 | None | 1.28A | 4ctjA-3s69A:undetectable | 4ctjA-3s69A:20.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3s9b | VIPERA RUSSELLIPROTEINASE RVV-VGAMMA (Daboiasiamensis) |
PF00089(Trypsin) | 6 | GLY A 142GLY A 44GLY A 196GLY A 193THR A 54VAL A 52 | None | 1.24A | 4ctjA-3s9bA:undetectable | 4ctjA-3s9bA:21.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3tvi | ASPARTOKINASE (Clostridiumacetobutylicum) |
PF00696(AA_kinase)PF01842(ACT) | 5 | GLY A 191GLY A 185GLU A 116VAL A 5ILE A 194 | NoneNoneASP A 451 (-3.9A)NoneNone | 0.85A | 4ctjA-3tviA:undetectable | 4ctjA-3tviA:21.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ugk | SACCHAROPINEDEHYDROGENASE [NAD+,L-LYSINE-FORMING] (Saccharomycescerevisiae) |
PF05222(AlaDh_PNT_N) | 5 | GLY A 140GLY A 200GLY A 203GLY A 208ILE A 250 | None | 0.86A | 4ctjA-3ugkA:undetectable | 4ctjA-3ugkA:21.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3vml | 3-ISOPROPYLMALATEDEHYDROGENASE (Shewanellabenthica;Shewanellaoneidensis) |
PF00180(Iso_dh) | 5 | GLY A 14GLY A 45GLY A 75GLY A 12ASP A 86 | None | 0.84A | 4ctjA-3vmlA:undetectable | 4ctjA-3vmlA:23.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3w9h | ACRIFLAVINERESISTANCE PROTEIN B (Escherichiacoli) |
PF00873(ACR_tran) | 5 | GLY A 290GLY A 288GLY A 179ASP A 328ILE A 291 | None | 0.81A | 4ctjA-3w9hA:undetectable | 4ctjA-3w9hA:14.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3zk4 | DIPHOSPHONUCLEOTIDEPHOSPHATASE 1 (Lupinus luteus) |
PF00149(Metallophos)PF14008(Metallophos_C)PF16656(Pur_ac_phosph_N) | 6 | GLY A 274GLY A 476GLY A 271GLY A 516VAL A 437ASP A 313 | NoneNoneNoneNoneNone MN A 801 (-2.6A) | 1.46A | 4ctjA-3zk4A:undetectable | 4ctjA-3zk4A:17.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3zq4 | RIBONUCLEASE J 1 (Bacillussubtilis) |
PF00753(Lactamase_B)PF07521(RMMBL) | 6 | GLY A 15GLY A 391GLY A 16GLU A 392VAL A 400ILE A 415 | None | 1.40A | 4ctjA-3zq4A:undetectable | 4ctjA-3zq4A:19.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3zsc | PECTATETRISACCHARIDE-LYASE (Thermotogamaritima) |
PF00544(Pec_lyase_C) | 6 | GLY A 137GLY A 83GLY A 102GLU A 63VAL A 52ILE A 98 | None | 1.26A | 4ctjA-3zscA:undetectable | 4ctjA-3zscA:20.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4a9w | MONOOXYGENASE (Stenotrophomonasmaltophilia) |
PF13738(Pyr_redox_3) | 5 | GLY A 11GLY A 321GLY A 129GLY A 10ASP A 324 | FAD A1353 ( 4.7A)FAD A1353 ( 4.5A)FAD A1353 (-3.6A)FAD A1353 (-3.0A)SO4 A1359 (-3.6A) | 0.86A | 4ctjA-4a9wA:undetectable | 4ctjA-4a9wA:21.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4auk | RIBOSOMAL RNA LARGESUBUNITMETHYLTRANSFERASE M (Escherichiacoli) |
PF01728(FtsJ) | 5 | GLY A 219GLY A 224TRP A 225ASP A 260ASP A 277 | EDO A1373 (-3.8A)NoneNoneNoneNone | 0.80A | 4ctjA-4aukA:12.5 | 4ctjA-4aukA:21.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4cjx | C-1-TETRAHYDROFOLATESYNTHASE,CYTOPLASMIC,PUTATIVE (Trypanosomabrucei) |
PF00763(THF_DHG_CYH)PF02882(THF_DHG_CYH_C) | 5 | GLY A 172GLY A 237GLY A 217GLY A 170VAL A 271 | NAP A1301 (-3.3A)NAP A1301 (-3.3A)NAP A1301 (-2.8A)NAP A1301 (-3.3A)None | 0.83A | 4ctjA-4cjxA:undetectable | 4ctjA-4cjxA:21.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4dk1 | PUTATIVE MACA,MULTIDRUG RESISTANCEPROTEIN MEXA (Pseudomonasaeruginosa;Aggregatibacteractinomycetemcomitans) |
PF16576(HlyD_D23) | 5 | GLY A 261GLY A 50GLU A 196VAL A 211ILE A 249 | None | 0.83A | 4ctjA-4dk1A:undetectable | 4ctjA-4dk1A:21.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4e7n | SNAKE-VENOMTHROMBIN-LIKE ENZYME (Gloydius halys) |
PF00089(Trypsin) | 6 | GLY A 142GLY A 44GLY A 196GLY A 193THR A 54VAL A 52 | None | 1.25A | 4ctjA-4e7nA:undetectable | 4ctjA-4e7nA:18.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4gc5 | DIMETHYLADENOSINETRANSFERASE 1,MITOCHONDRIAL (Mus musculus) |
PF00398(RrnaAD) | 6 | GLY A 63GLY A 65GLY A 68LYS A 86ASP A 111VAL A 112 | ACT A 402 (-3.4A)NoneNoneNoneNoneNone | 0.92A | 4ctjA-4gc5A:7.5 | 4ctjA-4gc5A:22.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4hzu | ENERGY-COUPLINGFACTOR TRANSPORTERATP-BINDING PROTEINECFA 2 (Lactobacillusbrevis) |
PF00005(ABC_tran) | 6 | GLY A 216THR A 24ASP A 9VAL A 26ASP A 214ILE A 213 | None | 1.49A | 4ctjA-4hzuA:undetectable | 4ctjA-4hzuA:20.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4jcn | GLUTAMYLENDOPEPTIDASE (Staphylococcusepidermidis) |
PF13365(Trypsin_2) | 5 | GLY A 248GLY A 104GLY A 236VAL A 131ILE A 112 | None | 0.85A | 4ctjA-4jcnA:undetectable | 4ctjA-4jcnA:18.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4k6m | POLYPROTEIN (Japaneseencephalitisvirus) |
PF00972(Flavi_NS5)PF01728(FtsJ) | 11 | GLY A 58GLY A 81GLY A 83GLY A 86THR A 104LYS A 105GLU A 111ASP A 131VAL A 132ASP A 146ILE A 147 | SAH A1001 (-3.1A)SAH A1001 (-3.3A)SAH A1001 ( 3.7A)SAH A1001 (-3.2A)SAH A1001 (-4.7A)NoneSO4 A1011 (-4.9A)SAH A1001 (-3.7A)SAH A1001 (-3.7A)SAH A1001 (-3.6A)SAH A1001 ( 4.3A) | 0.51A | 4ctjA-4k6mA:41.1 | 4ctjA-4k6mA:30.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4k6m | POLYPROTEIN (Japaneseencephalitisvirus) |
PF00972(Flavi_NS5)PF01728(FtsJ) | 9 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104GLU A 111ASP A 146ILE A 147 | SAH A1001 (-3.1A)SAH A1001 (-3.3A)SAH A1001 ( 3.7A)SAH A1001 (-3.2A)SAH A1001 (-3.9A)SAH A1001 (-4.7A)SO4 A1011 (-4.9A)SAH A1001 (-3.6A)SAH A1001 ( 4.3A) | 0.48A | 4ctjA-4k6mA:41.1 | 4ctjA-4k6mA:30.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4k6m | POLYPROTEIN (Japaneseencephalitisvirus) |
PF00972(Flavi_NS5)PF01728(FtsJ) | 6 | GLY A 81GLY A 85TRP A 87GLU A 111ASP A 146ILE A 147 | SAH A1001 (-3.3A)SAH A1001 (-4.3A)SAH A1001 (-3.9A)SO4 A1011 (-4.9A)SAH A1001 (-3.6A)SAH A1001 ( 4.3A) | 1.20A | 4ctjA-4k6mA:41.1 | 4ctjA-4k6mA:30.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4kru | AUTOLYTIC LYSOZYME (Clostridiumphage phiSM101) |
PF01183(Glyco_hydro_25) | 6 | GLY A 11GLY A 175TRP A 155ASP A 29ASP A 13ILE A 12 | NoneNoneNoneNoneNDG A 501 (-3.6A)None | 1.40A | 4ctjA-4kruA:undetectable | 4ctjA-4kruA:20.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4lrs | ACETALDEHYDEDEHYDROGENASE (Thermomonosporacurvata) |
PF01118(Semialdhyde_dh)PF09290(AcetDehyd-dimer) | 6 | GLY B 181GLY B 35GLY B 32GLY B 179THR B 36ILE B 28 | PEG B 409 ( 3.5A)NoneNAD B 401 (-3.2A)NAD B 401 (-3.5A)NoneNone | 1.20A | 4ctjA-4lrsB:undetectable | 4ctjA-4lrsB:19.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4n0q | LEU/ILE/VAL-BINDINGPROTEIN HOMOLOG 3 (Brucellamelitensis) |
PF13458(Peripla_BP_6) | 6 | GLY A 173GLY A 247GLY A 222THR A 269ASP A 355ASP A 143 | None | 1.42A | 4ctjA-4n0qA:undetectable | 4ctjA-4n0qA:21.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4n49 | CAP-SPECIFIC MRNA(NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1 (Homo sapiens) |
PF01728(FtsJ) | 5 | GLY A 279GLY A 282THR A 301ASP A 335ASP A 364 | SAM A 601 (-3.5A)SAM A 601 (-3.1A)SAM A 601 (-4.1A)SAM A 601 (-3.6A)SAM A 601 (-3.6A) | 0.55A | 4ctjA-4n49A:15.7 | 4ctjA-4n49A:21.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4phb | UNCHARACTERIZEDPROTEIN (Ruminiclostridiumthermocellum) |
PF14262(Cthe_2159) | 5 | GLY A 124GLY A 184GLY A 159GLU A 120ILE A 186 | None | 0.83A | 4ctjA-4phbA:undetectable | 4ctjA-4phbA:21.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ru5 | TAILSPIKE GP27 (Pseudomonasphage phi297) |
no annotation | 6 | GLY A 491GLY A 519GLY A 470THR A 520VAL A 522ILE A 548 | None | 1.26A | 4ctjA-4ru5A:undetectable | 4ctjA-4ru5A:18.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ynn | PROTEASE DO (Legionellapneumophila) |
PF13180(PDZ_2)PF13365(Trypsin_2) | 5 | GLY A 203GLY A 66GLY A 191VAL A 91ILE A 76 | None | 0.73A | 4ctjA-4ynnA:undetectable | 4ctjA-4ynnA:19.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4yo1 | DEGQ (Legionellapneumophila) |
PF13180(PDZ_2)PF13365(Trypsin_2) | 5 | GLY A 203GLY A 66GLY A 191VAL A 91ILE A 76 | None | 0.79A | 4ctjA-4yo1A:undetectable | 4ctjA-4yo1A:21.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5a22 | VESICULAR STOMATITISVIRUS L POLYMERASE (Vesicularstomatitisvirus) |
PF00946(Mononeg_RNA_pol)PF14314(Methyltrans_Mon)PF14318(Mononeg_mRNAcap) | 5 | GLY A1670GLY A1672GLY A1675ASP A1735ASP A1762 | None | 0.81A | 4ctjA-5a22A:12.2 | 4ctjA-5a22A:9.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5brr | TISSUE-TYPEPLASMINOGENACTIVATOR (Homo sapiens) |
PF00089(Trypsin) | 5 | GLY E 211GLY E 44GLY E 196VAL E 66ILE E 52 | None | 0.85A | 4ctjA-5brrE:undetectable | 4ctjA-5brrE:21.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ccx | TRNA(ADENINE(58)-N(1))-METHYLTRANSFERASECATALYTIC SUBUNITTRMT61A (Homo sapiens) |
PF08704(GCD14) | 6 | GLY A 111GLY A 113ASP A 163VAL A 164ASP A 181ILE A 182 | SAH A 301 (-3.2A)SAH A 301 (-2.9A)SAH A 301 (-2.7A)SAH A 301 (-4.0A)SAH A 301 (-2.4A)SAH A 301 ( 3.8A) | 0.78A | 4ctjA-5ccxA:8.9 | 4ctjA-5ccxA:21.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ccx | TRNA(ADENINE(58)-N(1))-METHYLTRANSFERASECATALYTIC SUBUNITTRMT61A (Homo sapiens) |
PF08704(GCD14) | 6 | GLY A 111GLY A 115ASP A 163VAL A 164ASP A 181ILE A 182 | SAH A 301 (-3.2A)SAH A 301 (-3.9A)SAH A 301 (-2.7A)SAH A 301 (-4.0A)SAH A 301 (-2.4A)SAH A 301 ( 3.8A) | 0.84A | 4ctjA-5ccxA:8.9 | 4ctjA-5ccxA:21.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5e9q | GENOME POLYPROTEIN (Dengue virus) |
PF01728(FtsJ) | 11 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105ASP A 131VAL A 132ASP A 146ILE A 147 | SAM A 301 (-3.2A)SAM A 301 (-3.3A)SAM A 301 (-3.1A)SAM A 301 (-3.1A)SAM A 301 (-3.6A)SAM A 301 (-4.6A)NoneSAM A 301 (-3.4A)SAM A 301 (-3.6A)SAM A 301 (-3.8A)SAM A 301 ( 4.2A) | 0.17A | 4ctjA-5e9qA:45.7 | 4ctjA-5e9qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5e9q | GENOME POLYPROTEIN (Dengue virus) |
PF01728(FtsJ) | 6 | GLY A 58GLY A 83GLY A 86THR A 104LYS A 105GLU A 111 | SAM A 301 (-3.2A)SAM A 301 (-3.1A)SAM A 301 (-3.1A)SAM A 301 (-4.6A)NoneSAM A 301 ( 3.4A) | 1.09A | 4ctjA-5e9qA:45.7 | 4ctjA-5e9qA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5gnd | PUTATIVE SERINEPROTEASE HHOA (Synechocystissp. PCC 6803) |
PF13180(PDZ_2)PF13365(Trypsin_2) | 5 | GLY A 250GLY A 114GLY A 238VAL A 138ILE A 123 | None | 0.84A | 4ctjA-5gndA:undetectable | 4ctjA-5gndA:21.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5gvt | PLASMA KALLIKREIN (Mus musculus) |
no annotation | 6 | GLY A 142GLY A 44GLY A 196GLY A 193THR A 54VAL A 52 | None | 1.27A | 4ctjA-5gvtA:undetectable | 4ctjA-5gvtA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hdm | GLUTAMATE-1-SEMIALDEHYDE 2,1-AMINOMUTASE1, CHLOROPLASTIC (Arabidopsisthaliana) |
PF00202(Aminotran_3) | 6 | GLY A 283GLY A 317GLY A 278GLY A 273THR A 320ILE A 318 | None | 1.38A | 4ctjA-5hdmA:undetectable | 4ctjA-5hdmA:21.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hxw | L-AMINO ACIDDEAMINASE (Proteusvulgaris) |
PF01266(DAO) | 5 | GLY A 66GLY A 257GLY A 61VAL A 271ILE A 420 | NoneFAD A 501 (-3.4A)FAD A 501 (-3.1A)NoneNone | 0.85A | 4ctjA-5hxwA:undetectable | 4ctjA-5hxwA:20.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5ikm | NS5 METHYLTRANSFERASE (Dengue virus) |
PF01728(FtsJ) | 11 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105ASP A 131VAL A 132ASP A 146ILE A 147 | SAM A 311 (-3.3A)SAM A 311 (-3.2A)SAM A 311 (-3.3A)SAM A 311 (-3.3A)SAM A 311 (-3.5A)SAM A 311 (-4.5A)MLT A 313 ( 3.0A)MLT A 313 ( 2.6A)SAM A 311 (-3.7A)SAM A 311 (-3.8A)SAM A 311 ( 4.3A) | 0.52A | 4ctjA-5ikmA:43.0 | 4ctjA-5ikmA:80.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5ikm | NS5 METHYLTRANSFERASE (Dengue virus) |
PF01728(FtsJ) | 6 | GLY A 81GLY A 58GLY A 86GLY A 83THR A 59ASP A 146 | SAM A 311 (-3.2A)SAM A 311 (-3.3A)SAM A 311 (-3.3A)SAM A 311 (-3.3A)NoneSAM A 311 (-3.8A) | 1.32A | 4ctjA-5ikmA:43.0 | 4ctjA-5ikmA:80.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5ikm | NS5 METHYLTRANSFERASE (Dengue virus) |
PF01728(FtsJ) | 9 | GLY A 81GLY A 83GLY A 86THR A 104LYS A 105GLU A 111ASP A 131VAL A 132ILE A 147 | SAM A 311 (-3.2A)SAM A 311 (-3.3A)SAM A 311 (-3.3A)SAM A 311 (-4.5A)MLT A 313 ( 3.0A)NoneMLT A 313 ( 2.6A)SAM A 311 (-3.7A)SAM A 311 ( 4.3A) | 0.78A | 4ctjA-5ikmA:43.0 | 4ctjA-5ikmA:80.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5jd8 | PERIPLASMIC SERINEPEPTIDASE DEGS (Yersinia pestis) |
PF13180(PDZ_2)PF13365(Trypsin_2) | 5 | GLY A 213GLY A 82GLY A 201VAL A 106ILE A 91 | None | 0.68A | 4ctjA-5jd8A:undetectable | 4ctjA-5jd8A:20.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5jjr | GENOME POLYPROTEIN (Dengue virus) |
PF00972(Flavi_NS5)PF01728(FtsJ) | 11 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105ASP A 131VAL A 132ASP A 146ILE A 147 | SAH A1003 (-3.2A)SAH A1003 (-3.4A)SAH A1003 (-3.5A)SAH A1003 (-3.0A)SAH A1003 (-3.4A)SAH A1003 (-4.6A)SAH A1003 (-4.8A)SAH A1003 (-3.0A)SAH A1003 (-3.7A)SAH A1003 (-3.8A)SAH A1003 ( 4.3A) | 0.49A | 4ctjA-5jjrA:43.9 | 4ctjA-5jjrA:99.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5jjr | GENOME POLYPROTEIN (Dengue virus) |
PF00972(Flavi_NS5)PF01728(FtsJ) | 6 | GLY A 58TRP A 87LYS A 105ASP A 131ASP A 146ILE A 147 | SAH A1003 (-3.2A)SAH A1003 (-3.4A)SAH A1003 (-4.8A)SAH A1003 (-3.0A)SAH A1003 (-3.8A)SAH A1003 ( 4.3A) | 1.44A | 4ctjA-5jjrA:43.9 | 4ctjA-5jjrA:99.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5kpg | PAVINEN-METHYLTRANSFERASE (Thalictrumflavum) |
PF02353(CMAS) | 5 | GLY A 135GLY A 137THR A 158ASP A 185VAL A 186 | SAH A 401 (-3.7A)SAH A 401 ( 3.8A)NoneSAH A 401 (-3.5A)SAH A 401 (-3.8A) | 0.58A | 4ctjA-5kpgA:8.3 | 4ctjA-5kpgA:21.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5nju | GENOME POLYPROTEIN (Zika virus) |
no annotation | 12 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105GLU A 111ASP A 131VAL A 132ASP A 146ILE A 147 | SAH A1001 (-3.3A)SAH A1001 (-3.4A)SAH A1001 (-3.4A)SAH A1001 (-3.3A)SAH A1001 (-3.5A)SAH A1001 (-4.4A)NoneNoneSAH A1001 (-3.9A)SAH A1001 (-3.6A)SAH A1001 (-3.7A)SAH A1001 (-4.2A) | 0.58A | 4ctjA-5njuA:40.4 | 4ctjA-5njuA:undetectable | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5tmh | POLYPROTEIN (Zika virus) |
PF00972(Flavi_NS5)PF01728(FtsJ) | 11 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104GLU A 111ASP A 131VAL A 132ASP A 146ILE A 147 | SAH A1001 (-3.2A)SAH A1001 (-3.4A)SAH A1001 ( 3.8A)SAH A1001 (-3.6A)SAH A1001 (-3.5A)SAH A1001 ( 4.9A)NoneSAH A1001 (-4.0A)SAH A1001 (-4.0A)SAH A1001 (-3.8A)SAH A1001 ( 4.8A) | 0.35A | 4ctjA-5tmhA:40.3 | 4ctjA-5tmhA:31.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5u4q | DTDP-GLUCOSE4,6-DEHYDRATASE (Klebsiellapneumoniae) |
PF16363(GDP_Man_Dehyd) | 5 | GLY A 183GLY A 13GLY A 186VAL A 5ILE A 16 | CL A 402 (-4.3A)None CL A 402 ( 4.4A)NoneNone | 0.78A | 4ctjA-5u4qA:4.5 | 4ctjA-5u4qA:20.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5y2d | - (-) |
no annotation | 5 | GLY A 234GLY A 102GLY A 222VAL A 126ILE A 111 | None | 0.86A | 4ctjA-5y2dA:undetectable | 4ctjA-5y2dA:undetectable |